N/A
N=26
Probiotics for Chalaziosis Treatment in Children
Chalazion
Bottom Line
View on ClinicalTrials.gov: NCT04322500 ↗Enrolled (actual)
26
Serious AEs
0.0%
Results posted
Apr 2020
Primary outcome: Primary: Time Taken for a Complete Resolution of the Chalaziosis — 51.2; 28.4 days
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- probiotics (Dietary_supplement); conservative treatment (Other)
- Age
- Pediatric · 3+ yrs
- Sex
- All
- Sponsor
- University of Molise
- Primary completion
- Feb 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Time Taken for a Complete Resolution of the Chalaziosis |
51.2; 28.4 | — |
| PRIMARY Number of Recurrences |
0; 0 | — |
Summary
There is growing evidence encouraging the use of probiotics in many conditions in children. The aim of the investigator's study is to define the possible beneficial impact of probiotics on paediatric patients affected by chalaziosis.
Eligibility Criteria
Inclusion Criteria
- paediatric patients
- presence of one or more eyelid mass lesions (history of rapid onset of painful inflamed mass that had reached a stationary size for more than 2 months)
Exclusion Criteria
- eyelid infection
- chalazion duration < 1 month
- nonpalpable chalazion
- suspicion of malignancy
Data sourced from ClinicalTrials.gov (NCT04322500). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.